Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2009 Aug 3;24(5):673–679. doi: 10.1002/ptr.2955

Comparative study on the antiviral activity of selected monoterpenes derived from essential oils

Akram Astani 1,2, Jürgen Reichling 3, Paul Schnitzler 1,
PMCID: PMC7167768  PMID: 19653195

Abstract

Essential oils are complex natural mixtures, their main constituents, e.g. terpenes and phenylpropanoids, being responsible for their biological properties. Essential oils from eucalyptus, tea tree and thyme and their major monoterpene compounds α‐terpinene, γ‐terpinene, α‐pinene, p‐cymene, terpinen‐4‐ol, α‐terpineol, thymol, citral and 1,8‐cineole were examined for their antiviral activity against herpes simplex virus type 1 (HSV‐1) in vitro. These essential oils were able to reduce viral infectivity by >96%, the monoterpenes inhibited HSV by about >80%. The mode of antiviral action has been determined, only moderate antiviral effects were revealed by essential oils and monoterpenes when these drugs were added to host cells prior to infection or after entry of HSV into cells. However, both essential oils and monoterpenes exhibited high anti‐HSV‐1 activity by direct inactivation of free virus particles. All tested drugs interacted in a dose‐dependent manner with herpesvirus particles thereby inactivating viral infection. Among the analysed compounds, monoterpene hydrocarbons were slightly superior to monoterpene alcohols in their antiviral activity, α‐pinene and α‐terpineol revealed the highest selectivity index. However, mixtures of different monoterpenes present in natural tea tree essential oil revealed a ten‐fold higher selectivity index and a lower toxicity than its isolated single monoterpenes. Copyright © 2009 John Wiley & Sons, Ltd.

Keywords: essential oils, monoterpenes, herpes simplex virus, antiviral activity, mode of action, selectivity index

REFERENCES

  1. Amoros M, Simoes CMO, Girre L, Sauvager F, Cormier M. 1992. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. J Nat Prod 55: 1732–1740. [DOI] [PubMed] [Google Scholar]
  2. Armaka M, Papanikolaou E, Sivropoulou A, Arsenakis M. 1999. Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1. Antiviral Res 43: 79–92. [DOI] [PubMed] [Google Scholar]
  3. Benencia F, Courrèges MC. 1999. Antiviral activity of sandalwood oil against herpes simplex viruses‐1 and ‐2. Phytomedicine 6: 119–123. [DOI] [PubMed] [Google Scholar]
  4. Blaschek W, Ebel S, Hackenthal E et al. 2005. Hagers Handbuch der Drogen und Arzneistoffe, Hager ROM. (ed.). Springer Verlag: Berlin, Heidelberg, New York. [Google Scholar]
  5. Bourne KZ, Bourne N, Reising SF, Stanberry LR. 1999. Plant products as topical microbicide candidates: assessment of in vitro activity against herpes simplex virus type 2. Antiviral Research 42: 219–226. [DOI] [PubMed] [Google Scholar]
  6. Carson CF, Ashton L, Dry L, Smith DW, Riley TV. 2001. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother 48: 450–451. [DOI] [PubMed] [Google Scholar]
  7. Carson CF, Hammer KA, Riley TV. 2006. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19: 50–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cassady KA, Whitley RJ. 1997. New therapeutic approaches to the alphaherpesvirus infections. J Antimicrob Chemother 39: 119–128. [DOI] [PubMed] [Google Scholar]
  9. Cermelli C, Fabio A, Fabio G, Quaglio P. 2008. Effect of eucalyptus essential oil on respiratory bacteria and viruses. Curr Microbiol 56: 89–92. [DOI] [PubMed] [Google Scholar]
  10. Christoph F, Kaulfers PM, Stahl‐Biskup E. 2000. A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with special reference to the activities of β‐triketones. Planta Med 66: 556–560. [DOI] [PubMed] [Google Scholar]
  11. Cos P, Maes L, Vlietinck A, Pieters L. 2008. Plant‐derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection – an update (1998–2007). Planta Med 74: 1323–1337. [DOI] [PubMed] [Google Scholar]
  12. Cos P, Vlietinck AJ, Berghe DV, Maes L. 2006. Anti‐infective potential of natural products: how to develop a stronger in vitro ‘proof‐of‐concept’. J Ethnopharmacol 106: 290–302. [DOI] [PubMed] [Google Scholar]
  13. Cox SD, Mann CM, Markham JL. 2001. Interactions between components of the essential oil of Melaleuca alternifolia . J Appl Microbiol 91: 492–497. [DOI] [PubMed] [Google Scholar]
  14. De Clercq E. 2004. Antiviral drugs in current clinical use. J Clin Virol 30: 115–133. [DOI] [PubMed] [Google Scholar]
  15. De Logu A, Loy G, Pellerano ML, Bonsignore L, Schivo ML. 2000. Inactivation of HSV‐1 and HSV‐2 and prevention of cell‐to‐cell virus spread by Santolina insularis essential oil. Antiviral Res 48: 177–185. [DOI] [PubMed] [Google Scholar]
  16. Farag RS, Shalaby AS, El‐Baroty GA, Ibrahim NA, Ali MA, Hassan EM. 2004. Chemical and biological evaluation of the essential oils of different Melaleuca species. Phytother Res 18: 30–35. [DOI] [PubMed] [Google Scholar]
  17. Hayashi K, Hayashi T, Ujita K, Takaishi Y. 1996. Characterization of antiviral activity of a sesquiterpene, triptofordin C‐2. J Antimicrob Chemother 37: 759–768. [DOI] [PubMed] [Google Scholar]
  18. Koch C, Reichling J, Schneele J, Schnitzler P. 2008. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine 15: 71–78. [DOI] [PubMed] [Google Scholar]
  19. Koytchev R, Alken RG, Dundarov S. 1999. Balm mint extract (Lo‐701) for topical treatment of recurring herpes labialis. Phytomedicine 6: 225–230. [DOI] [PubMed] [Google Scholar]
  20. Niedermeyer TH, Lindequist U, Mentel R et al. 2005. Antiviral terpenoid constituents of Ganoderma pfeifferi . J Nat Prod 68: 1728–1731. [DOI] [PubMed] [Google Scholar]
  21. Pusztai R, Hohmann J, Rédei D, Engi H, Molnár J. 2008. Inhibition of human cytomegalovirus IE gene expression by dihydro‐beta‐agarofuran sesquiterpenes isolated from Euonymus species. In Vivo 22: 787–792. [PubMed] [Google Scholar]
  22. Reichling J. 1999. Plant‐microbe interaction and secondary metabolites with antiviral, antibacterial and antifungal properties In: Wink M. (ed.) Functions of plant secondary metabolites and their exploitation in biotechnology. Annual Plant Review, Vol. 3. Sheffield Acad. Press, Sheffield, pp. 187–273. [Google Scholar]
  23. Reichling J, Koch C, Stahl‐Biskup E, Sojka C, Schnitzler P. 2005. Virucidal activity of a beta‐triketone‐rich essential oil of Leptospermum scoparium (manuka oil) against HSV‐1 and HSV‐2 in cell culture. Planta Med 71: 1123–1127. [DOI] [PubMed] [Google Scholar]
  24. Reusser P. 1996. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 3: 235–248. [DOI] [PubMed] [Google Scholar]
  25. Rollinger JM, Steindl TM, Schuster D et al. 2008. Structure‐based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein. J Med Chem 51: 842–451. [DOI] [PubMed] [Google Scholar]
  26. Saller R, Buechi S, Meyrat R, Schmidhauser C. 2001. Combined herbal preparation for topical treatment of herpes labialis. Forsch Komplementarmed Klass Naturheilkd 8: 373–382. [DOI] [PubMed] [Google Scholar]
  27. Schnitzler P, Koch C, Reichling J. 2007. Susceptibility of drug‐resistant clinical HSV‐1 strains to essential oils of ginger, thyme, hyssop and sandalwood. Antimicrob Agents Chemother 51: 1859–1862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schnitzler P, Nolkemper S, Stintzing FC, Reichling J. 2008. Comparative in vitro study on the anti‐herpetic effect of phytochemically characterized aqueous and ethanolic extracts of Salvia officinalis grown at two different locations. Phytomedicine 15: 62–70. [DOI] [PubMed] [Google Scholar]
  29. Schnitzler P, Schön K, Reichling J. 2001. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie 56: 343–347. [PubMed] [Google Scholar]
  30. Schuhmacher A, Reichling J, Schnitzler P. 2003. Virucidal effect of eucalyptus oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro . Phytomedicine 10: 504–510. [DOI] [PubMed] [Google Scholar]
  31. Siddiqui YM, Ettayebi M, Haddad AM, Al‐Ahdal MN. 1996. Effect of essential oils on the enveloped viruses: antiviral activity of oregano and clove oils on herpes simplex virus type 1 and Newcastle disease virus. Med Sci Res 24: 185–186. [Google Scholar]
  32. Söderberg T, Johannson A, Gref R. 1996. Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells. Toxicology 107: 99–109. [DOI] [PubMed] [Google Scholar]
  33. Stranska R, Schuurman R, Nienhuis E et al. 2005. Survey of acyclovir‐resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 32: 7–18. [DOI] [PubMed] [Google Scholar]
  34. Tragoolpua Y, Jatisatieur A. 2007. Anti‐herpes simplex virus activities of Eugenia caryophyllus (Spreng.) Bullock & S. G. Harrison and essential oil, eugenol. Phytotherapy Research 21: 1153–1158. [DOI] [PubMed] [Google Scholar]
  35. Vanden Berghe DA, Vlietinck AJ, Van Hoof L. 1986. Plant products as potential antiviral agents. Bull Inst Pasteur 84: 101–147. [Google Scholar]
  36. Wen CC, Kuo YH, Jan JT et al. 2007. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 50: 4087–4095. [DOI] [PubMed] [Google Scholar]
  37. Whitley RJ, Roizman B. 2001. Herpes simplex virus infections. Lancet 357: 1513–1518. [DOI] [PubMed] [Google Scholar]
  38. Wölbling RH, Leonhardt K. 1994. Local therapy of herpes simplex with dried essential oil from Melissa officinalis . Phytomedicine 1: 25–31. [DOI] [PubMed] [Google Scholar]

Articles from Phytotherapy Research are provided here courtesy of Wiley

RESOURCES